PHYTOCHEMICAL SCREENING AND ANTIMICROBIAL ACTIVITY OF BLUMEA MOLLIS (D.DON) MERRILL

Objective: The objective of this research was to carry out the preliminary phytochemical screening and to evaluate the antimicrobial activity of the methanolic extract of the Blumea mollis. Methods: In the present work, the phytochemicals of the whole plant were extracted using petroleum ether, chloroform, methanol, ethanol, and distilled water. These were then screened for triterpenes/steroids, alkaloids, anthraquinones, coumarins, flavonoids, saponins, tannins, and phenolic acids using standard methods. Further, the antimicrobial activity of the methanolic extract was determined using Gram-positive and negative bacteria. Agar well diffusion method was employed for antimicrobial activity study, and the zone of inhibition was found out. Results: The intensity of the color produced or the precipitate formed was used as the analytical response to these tests. Flavonoids, tannins, and phenolic acids showed positive results for phytochemical screening. The concentration of total phenols and flavonoids of the decoction was 45.5±0.2000 μg/ml gallic acid equivalent and 42.3±0.3606 μg/ml quercetin equivalent, respectively. Staphylococcus aureus, Escherichia coli, and Candida albicans were inhibited by the methanolic extract of B. mollis in agar well diffusion test. Conclusion: The results of the present study showed that the methanolic extract of B. mollis contains glycosides, phenolics, tannins, and flavonoids. Plant possesses significant antibacterial and antifungal property; the potent antimicrobial activity of the plant could be attributed to the presence of flavonoids and phenolic compounds in it

Seven-year-olds’ recollection of non-adjacent dependencies after overnight retention

Becoming a successful speaker depends on acquiring and learning grammatical dependencies between neighboring and non-neighboring linguistic elements (non-adjacent dependencies; NADs). Previous studies have demonstrated children’s and adults’ ability to distinguish NADs from NAD violations right after familiarization. However, demonstrating NAD-recollection and processing after retention is crucial to demonstrate NAD-learning. We tested 7-year-old’s NAD-learning in a natural, non-native language on one day and NADrecollection on the next day by means of event-related potentials (ERPs). Our results revealed ERPs with a more positive amplitude to NAD violations than correct NADs after familiarization on day one, but ERPs with a more negative amplitude to NAD violations on day two. This change from more positive to more negative ERPs to NAD violations possibly indicates that children’s representations of NADs changed during an overnight retention period, potentially associated with children’s NAD-learning. Indeed, both ERP patterns (i.e., day one: positive, day two: negative) were related to stronger behavioral improvement (i.e., more correct answers on day two compared to day one) in a grammaticality judgment task from day one to day two. We suggest these findings to indicate that children showing more correct answers at day two, compared to day one, successfully built associative representations of NADs on day one and then successfully strengthened these associations during overnight retention, revealing NAD-recollection on day two. The present results suggest that 7-year-olds readily track NADs in a natural, non-native language and are able to show recollection after a retention period involving sleep, providing strong evidence of NAD recollection

Virtual Touch (TM) Quantification to Diagnose and Monitor Liver Fibrosis in Hepatitis B and Hepatitis C: A NICE Medical Technology Guidance

King’s Technology Evaluation Centre is funded by NICE to act as an External Assessment Centre for the Medical Technologies Evaluation Programme. The NHS has a financial interest in the guidance issued by NICE as a result of this work and two authors are NHS employees (Prof. Keevil and Dr. Lewis

Withania somnifera Root Extract Enhances Chemotherapy through ‘Priming’

Withania somnifera extracts are known for their anti-cancerous, anti-inflammatory and antioxidative properties. One of their mechanisms of actions is to modulate mitochondrial function through increasing oxidative stress. Recently ‘priming’ has been suggested as a potential mechanism for enhancing cancer cell death. In this study we demonstrate that ‘priming’, in HT-29 colon cells, with W. somnifera root extract increased the potency of the chemotherapeutic agent cisplatin. We have also showed the W. somnifera root extract enhanced mitochondrial dysfunction and that the underlying mechanism of ‘priming’ was selectively through increased ROS. Moreover, we showed that this effect was not seen in non-cancerous cells

Selective Cholinergic Depletion in Medial Septum Leads to Impaired Long Term Potentiation and Glutamatergic Synaptic Currents in the Hippocampus

Cholinergic depletion in the medial septum (MS) is associated with impaired hippocampal-dependent learning and memory. Here we investigated whether long term potentiation (LTP) and synaptic currents, mediated by alpha-amino-3-hydroxy-5-methyl-isoxazole-4-propionate (AMPA) and N-methyl-D-aspartate (NMDA) receptors in the CA1 hippocampal region, are affected following cholinergic lesions of the MS. Stereotaxic intra-medioseptal infusions of a selective immunotoxin, 192-saporin, against cholinergic neurons or sterile saline were made in adult rats. Four days after infusions, hippocampal slices were made and LTP, whole cell, and single channel (AMPA or NMDA receptor) currents were recorded. Results demonstrated impairment in the induction and expression of LTP in lesioned rats. Lesioned rats also showed decreases in synaptic currents from CA1 pyramidal cells and synaptosomal single channels of AMPA and NMDA receptors. Our results suggest that MS cholinergic afferents modulate LTP and glutamatergic currents in the CA1 region of the hippocampus, providing a potential synaptic mechanism for the learning and memory deficits observed in the rodent model of selective MS cholinergic lesioning

Variation in the provision and practice of implant-based breast reconstruction in the UK: Results from the iBRA national practice questionnaire

Introduction The introduction of biological and synthetic meshes has revolutionised the practice of implant-based breast reconstruction (IBBR) but evidence for effectiveness is lacking. The iBRA (implant Breast Reconstruction evAluation) study is a national trainee-led project that aims to explore the practice and outcomes of IBBR to inform the design of a future trial. We report the results of the iBRA National Practice Questionnaire (NPQ) which aimed to comprehensively describe the provision and practice of IBBR across the UK. Methods A questionnaire investigating local practice and service provision of IBBR developed by the iBRA Steering Group was completed by trainee and consultant leads at breast and plastic surgical units across the UK. Summary data for each survey item were calculated and variation between centres and overall provision of care examined. Results 81 units within 79 NHS-hospitals completed the questionnaire. Units offered a range of reconstructive techniques, with IBBR accounting for 70% (IQR:50–80%) of participating units' immediate procedures. Units on average were staffed by 2.5 breast surgeons (IQR:2.0–3.0) and 2.0 plastic surgeons (IQR:1.0–3.0) performing 35 IBBR cases per year (IQR:20-50). Variation was demonstrated in the provision of novel different techniques for IBBR especially the use of biological (n = 62) and synthetic (n = 25) meshes and in patient selection for these procedures. Conclusions The iBRA-NPQ has demonstrated marked variation in the provision and practice of IBBR in the UK. The prospective audit phase of the iBRA study will determine the safety and effectiveness of different approaches to IBBR and allow evidence-based best practice to be explored